A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03035110|
Recruitment Status : Recruiting
First Posted : January 27, 2017
Last Update Posted : May 8, 2017
|Condition or disease||Intervention/treatment||Phase|
|Self-Injurious Behavior||Behavioral: Dialectical Behavioural Therapy (DBT) based skills groups||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings|
|Actual Study Start Date :||April 18, 2017|
|Estimated Primary Completion Date :||February 1, 2018|
|Estimated Study Completion Date :||February 1, 2018|
Experimental: Dialectical Behavioural Therapy (DBT) skills group
Four group sessions, based on DBT, over two weeks, with a group of four to eight participants in attendance located on the hospital ward where the participant is a patient.
Behavioral: Dialectical Behavioural Therapy (DBT) based skills groups
Dialectical Behavioural Therapy (DBT) involves skills that help people manage their emotions and tolerate distress. This therapy is found effective in reducing self-harm behaviour for outpatients with Borderline Personality Disorder.
- The Inventory of Statements About Self-Injury (ISAS) [ Time Frame: 23 days ]ISAS is a self-report measure designed to assess the function and frequency of deliberate self-harm. It will be administered pre- and post-intervention.
- The Distress Tolerance Scale (DTS) [ Time Frame: 23 days ]The DTS consists of 15 items, which measure a person's appraisal of their emotional distress, their ability to tolerate this distress and any regulation efforts to alleviate it. It will be administered pre- and post-intervention.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03035110
|Contact: Sarah Fife, BSc, MScfirstname.lastname@example.org|
|Contact: Sarah Research Governance and Planning Manageremail@example.com|
|Ilford, Essex, United Kingdom, IG3 8XJ|
|Contact: Lisa Wood, Clinical Psychology Doctorate 00441206874143 firstname.lastname@example.org|